Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ST. LOUIS, May 19, 2025 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) announced today it will provide support to The Urban League of Metropolitan St. Louis following the recent...
-
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
Stranger Things Have Happened: Brett Gelman gets a creative makeover in a new Fiverr ad campaign debuting today
-
Aquila and Kantar Media Successfully Launch Calibration Panel in 1,000+ Homes, Marking Significant Milestone Expanded Leadership Team, Collaboration with Accenture and Strong Brand Commitments Propel...
-
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
-
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
COLUMBUS, Ohio, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., a leader in Microsoft management and security, today announced that Cayosoft Guardian Forest Recovery™ has been named the winner in...
-
COLUMBUS, Ohio, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., a leader in Microsoft management and security, today announced it has become a member of the Microsoft Intelligent Security...
-
COLUMBUS, Ohio, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., the leader in Microsoft Active Directory management, monitoring, and recovery, has secured the patent for its flagship product,...
-
EXTON, PA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Since its 2017 debut as the first advanced systemic treatment for atopic dermatitis (AD), Sanofi/Regeneron’s Dupixent has dominated the US market....